Hong Kong stocks are moving differently | BeiGene Bio (06955.HK) surged more than 4% in the afternoon, with the application for two subcutaneous antiphospholipid injection solutions being accepted by the UK MHRA.

Smart Finance and M&A App learned that Boan Bio (06955.HK) rose more than 4% in the afternoon, as of the time of publication, it rose 4.13% to 10.34 Hong Kong dollars, with a turnover of 31.686 million Hong Kong dollars.